Alexander S. Oldroyd

Manchester, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Anti-Sp4 and anti-CCAR1 autoantibodies in UK vs US patients with adult and juvenile-onset anti-TIF1γ-positive myositis.

Anti-Sp4 and anti-CCAR1 autoantibodies in UK vs US patients with adult and juvenile-onset anti-TIF1γ-positive myositis.

Journal: Rheumatology (Oxford, England)

Published: July 22, 2024

Author Correction: International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative.

Author Correction: International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative.

Journal: Nature reviews. Rheumatology

Published: March 29, 2024

Remotely collected patient-reported data characterises the impact of idiopathic inflammatory myopathy flares upon work productivity.

Remotely collected patient-reported data characterises the impact of idiopathic inflammatory myopathy flares upon work productivity.

Journal: Rheumatology (Oxford, England)

Published: December 13, 2023

International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative.

International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative.

Journal: Nature reviews. Rheumatology

Published: October 05, 2023

Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: results from the MYONET registry.

Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: results from the MYONET registry.

Journal: Rheumatology (Oxford, England)

Published: April 19, 2023

Investigating characteristics of idiopathic inflammatory myopathy flares using daily symptom data collected via a smartphone app.

Investigating characteristics of idiopathic inflammatory myopathy flares using daily symptom data collected via a smartphone app.

Journal: Rheumatology (Oxford, England)

Published: November 19, 2021

Corrigendum to: A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies.

Corrigendum to: A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies.

Journal: Rheumatology (Oxford, England)

Published: October 24, 2021

British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy.

British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy.

Journal: Rheumatology (Oxford, England)

Published: July 06, 2021

A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies.

A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies.

Journal: Rheumatology (Oxford, England)

Published: December 04, 2020

Patient insights on living with idiopathic inflammatory myopathy and the limitations of disease activity measurement methods - a qualitative study.

Patient insights on living with idiopathic inflammatory myopathy and the limitations of disease activity measurement methods - a qualitative study.

Journal: BMC rheumatology

Published: March 11, 2020

Long-term strength and functional status in inclusion body myositis and identification of trajectory subgroups.

Long-term strength and functional status in inclusion body myositis and identification of trajectory subgroups.

Journal: Muscle & nerve

Published: July 26, 2019

Comment on: The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody-positive dermatomyositis: Reply.

Comment on: The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody-positive dermatomyositis: Reply.

Journal: Rheumatology (Oxford, England)

Published: June 25, 2019

Showing 1-12 of 24

Last Updated: 09/26/2026